Detalles de la búsqueda
1.
Distinct innate and adaptive immunity phenotypic profile at the circulating single-cell level in Psoriatic Arthritis.
Clin Immunol
; 253: 109679, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37336253
2.
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Br J Cancer
; 122(10): 1461-1466, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32210365
3.
Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001.
Cancer Immunol Immunother
; 61(2): 157-168, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21858533
4.
Small Extracellular Vesicles in Pre-Therapy Plasma Predict Clinical Outcome in Non-Small-Cell Lung Cancer Patients.
Cancers (Basel)
; 13(9)2021 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33922569
5.
Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
Anticancer Res
; 41(2): 661-670, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33517270
6.
Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer.
Cells
; 8(12)2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31847487
7.
Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment.
Lung Cancer
; 135: 33-39, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31447000
8.
CD8+ PD-1+ T-cells and PD-L1+ circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance?
Ther Adv Med Oncol
; 11: 1758835919853193, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217824
9.
Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes.
Mol Oncol
; 12(1): 21-32, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28766847
10.
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer.
Ther Adv Med Oncol
; 10: 1758834017750121, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29383038
11.
Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients.
Sci Rep
; 6: 39247, 2016 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27976733
12.
Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells' Subpopulations in the Peripheral Blood of Patients with Non-Small Cell Lung Cancer.
J Thorac Oncol
; 11(8): 1263-1272, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27178984
13.
Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel disease.
Ann Gastroenterol
; 29(2): 180-7, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27065731
14.
Infectious mononucleosis and Epstein-Barr virus.
Expert Rev Mol Med
; 6(23): 1-16, 2004 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15541197
15.
A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
J Immunol Res
; 2014: 659294, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25436215
16.
A phase II trial evaluating the clinical and immunologic response of HLA-A2(+) non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide.
Lung Cancer
; 86(1): 59-66, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25130084
17.
Sequential administration of the native TERT572 cryptic peptide enhances the immune response initiated by its optimized variant TERT(572Y) in cancer patients.
J Immunother
; 34(9): 641-50, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21989412
Resultados
1 -
17
de 17
1
Próxima >
>>